Effect of holoBLG on Cat Allergic Patients

NCT ID: NCT05455749 Phase: NA Status: COMPLETED Enrollment: 42 Completion: 2022-03-16

Conditions

Allergy to Cats, Allergic Rhinoconjunctivitis

Interventions

holoBLG

Summary

The aim of the study is to investigate the antigen-unspecific effect of a 3 months supplementation with a food for special medical purposes (FSMP) in form of a lozenge containing beta-lactoglobulin (BLG), iron, retinoic acid, zinc and polyphenols (holo-BLG) in patients with allergic rhinoconjunctivitis caused by cat (hair/dander) and the associated symptoms (symptom type and severity) during exposure to cat allergen in an Allergen Exposure Chamber (AEC).

Primary Outcome

TSS

Source

ClinicalTrials.gov